AMGN.O,Addition of Amgen drug boosts benefits in relapsed myeloma -study Dec 6 Significantly more patients with relapsed multiple myeloma responded to a three-drug regimen including Amgen Inc's Kyprolis than those who got the standard two-drug treatment, according to results from a late-stage trial. ~
BMY,High rate of lymphoma patients respond to Bristol-Myers drug-study Dec 6 Eighty-seven percent of Hodgkin lymphoma patients responded to a  Bristol-Myers Squibb drug that helps the immune system fight the blood cancer, according to data from a small, early stage trial released on Saturday. ~
CBS,UPDATE 2-CBS, Dish reach deal after CBS pulls programming (Adds more details about the deal, previous dateline Washington) ~Deal will keep CBS programming on Dish network WASHINGTON, Dec 6 CBS Corp and Dish Network Corp have reached a multi-year agreement that will continue delivering the network's programming to Dish's 14 million subscribers, ending a dispute between the two companies. ~CBS pulls programming off Dish Network in several U.S. markets Dec 5 CBS programming will no longer be available to Dish subscribers in New York, Los Angeles, San Francisco and other markets, after CBS Corp and Dish Network Corp failed to agree on a new contract. ~CBS programming pulled off Dish in several markets Dec 5 CBS statement: CBS programming is no longer available to Dish subscribers in New York, Los Angeles, San Francisco and other markets    (Reporting by Lisa Richwine) ~
CL,Preview: Colgate at Ohio State Ohio State looks to bounce back from its first loss of the season and wrap up a perfect run through the Buckeye Classic when the 13th-ranked Buckeyes host Colgate on Saturday. Ohio State is coming off a 64-55 loss at No. 5 Louisville on Tuesday in which the Buckeyes carved a 19-point deficit to four before falling short. The Raiders are off to a 1-6 start, but all of their losses have come by seven points or fewer. ~
MRK,Merck immunotherapy drug shows promise against lymphoma -study Dec 6 Merck & Co Inc's drug that harnesses the immune system to fight cancer showed promise in Hodgkin lymphoma patients whose disease had progressed following prior therapies, according to data from a small, early stage trial being presented at a medical meeting. ~Merck in talks to acquire Cubist Pharmaceuticals for more than $7 billion: NYT Merck & Co Inc is in talks to acquire Cubist Pharmaceuticals Inc for more than $7 billion in a deal that could be announced as early as next week, the New York Times reported on Friday, citing people briefed on the matter. ~
UTX,Former CEO of UTC questioned by directors on decreasing involvement: WSJ United Technologies Corp's former Chief Executive Officer Louis Chenevert, who retired abruptly, made a trip to Taiwan two weeks before his retirement to check on the construction of his yacht, the Wall Street Journal reported citing sources. ~Former CEO of UTC questioned by directors on decreasing involvement -WSJ Dec 5 United Technologies Corp's former Chief Executive Officer Louis Chenevert, who retired abruptly, made a trip to Taiwan two weeks before his retirement to check on the construction of his yacht, the Wall Street Journal reported citing sources. ~
